# Execution report: 3R.3 batch7 (omp/pi openai-codex/gpt-5.6-luna:xhigh)

Saved by dispatching ZCode main owner from the runner stream.

---

STATUS: COMPLETED  
Delegated batch7 artifacts and targeted verification completed; acceptance remains with the dispatching main owner.

FILES_CREATED:
- 13 ChapterContractV2 files under `chapter_contracts/`
- 13 Chinese ChapterSkillManifest files under `chapter_skills/`
- `tests/fixtures/protocol_v3/chapter_content_v2/batch7.json`
- `tests/protocol_v3/test_chapter_batch7.py`
- 5 pytest XML diagnostics under `runs/mw_protocol_v3_3r3_batch7_20260911/`

RED_EVIDENCE:
- `runs/mw_protocol_v3_3r3_batch7_20260911/red_stage1_missing_test.xml` — missing test-file collection failure
- `runs/mw_protocol_v3_3r3_batch7_20260911/red_stage2_failing_assertions.xml` — test present, missing artifacts produced failures/errors

GREEN_EVIDENCE:
- Exact command:
  `env -i PATH=/Users/smkzw/.local/bin:/opt/homebrew/bin:/usr/bin:/bin HOME=/Users/smkzw TMPDIR=/var/folders/yb/31r9763x6_54mdxswxk36c4w0000gn/T/ LANG=en_US.UTF-8 PYTHONDONTWRITEBYTECODE=1 PYTHONNOUSERSITE=1 PYTHONPATH=tests/protocol_v3:services/api:packages:. runs/mw_protocol_v3_1r_integration_20260905/venv/bin/python -m pytest tests/protocol_v3/test_chapter_batch7.py -q -p no:cacheprovider --tb=short --junitxml=runs/mw_protocol_v3_3r3_batch7_20260911/green_final.xml`
- Tail summary: `13 passed in 2.63s`
- XML: `runs/mw_protocol_v3_3r3_batch7_20260911/green_final.xml`

FIXTURES:
- Total: 59
- Positive: 13
- Missing-control: 12
- Missing-claim: 4
- Wrong-source: 17
- Skeleton: 13
- Source-specific negatives:
  - `v2_n_12_1`: copied company name → `forbidden_fact_present`
  - `v2_n_12_7`: study data conflated with future use → `missing_required_claim`
  - `v2_n_12_8`: blank custody and duration fields → `missing_required_fact`
  - `v2_n_12_9`: nonexistent repository → `forbidden_claim_present`
  - `v2_n_13_1`: unsigned plan claimed approved → `forbidden_claim_present`
  - `v2_n_13_2`: future-use permission inferred from ordinary consent → `forbidden_claim_present`
  - `v2_n_13_4`: missing mandatory compensation arrangement → `missing_required_fact`

SEMANTIC_NOTES:
- Future-use separation: `v2_n_12_7`; purpose, location, duration, genetic testing, consent, review, and separation from current-study assays are independently typed. `v2_n_13_2` forbids deriving future-use permission from ordinary trial consent.
- Retention arrangement: `v2_n_12_8` requires trigger, duration, custody, disposition, record types, and storage location; universal five-year, optical-disc, and sponsor-ownership assumptions are forbidden.
- Ethics/consent prospective semantics: `v2_n_13_1` and `v2_n_13_2` require prospective procedure, version, responsible role, timing before relevant procedures, capacity/representative handling, applicable witness handling, and new-information handling. Approval-ready text does not assert approval obtained.
- Confidentiality recipients and transfer: `v2_n_13_3` separately requires data coding, sample coding, recipients, access control, transfer arrangements, and retention linkage.
- Compensation resolution: `v2_n_13_4` requires arrangement, injury procedure, insurance/guarantee, responsible contact, and missing-fact resolution rather than declaring the section inapplicable.
- Direct eCRF source data and copied source records remain distinct in `v2_n_12_2`.
- All thirteen contracts populate `word_rules.required_styles` and `required_bookmarks` from `node_tree.json`.

DEFERRED:
- Primary-source validation of GCP article numbers and retention/consent legal wording.
- Actual project fact confirmation, clinical judgment, legal adequacy, ethics approval, compensation agreements, and native Word rendering acceptance.
- Full 3R.3 cross-contract acceptance and parent-node aggregation.
- Runtime/provider/model activation.

LIMITS_AND_NEXT:
- Verification covered only the batch7 targeted test and its partial/full lint assertions; no full-project suite was run.
- Main owner should perform combined-batch assembly, cross-contract vocabulary lint, semantic review of the 13 carriers, and final 3R.3 acceptance.